Philip Anthony Harris

This inventor holds 26 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 6 EPO patents, primarily in Kinase Inhibitors. Top assignees: Smithkline Beecham Corporation, Glaxosmithkline Intellectual Property Development Limited, Glaxosmithkline LLC. Active years: 2001-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philip Anthony Harris. Retrieved from https://idiyas.com/inventor/philip-anthony-harris

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 26 (Patent Applications = 9)

% Patents Active = 50.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 8)

Average Co-Inventor Count = 7.6

ph-index = 10

Forward Citations = 452(Granted Patents)

Location History:

Raleigh, NC (US) (2001 - 2006)
Durham, NC (US) (2003 - 2010)
Wayne, PA (US) (2010 - 2012)
Collegeville, PA (US) (2017 - 2022)

Company Filing History:

14 out of 2,198

Smithkline Beecham Corporation

patents

7 out of 242

Glaxosmithkline Intellectual Property Development Limited

Years Active: 2001-2022

Loading Chart...

Areas of Expertise:

Heterocyclic Amides

Angiogenesis Modulators

Pyrazolopyridines

Kinase Inhibitors

Chemical Compounds

Pyrimidineamines

Oxindole Derivatives

Therapeutic Compounds

Protein Tyrosine Kinase

Serine/Threonine Kinase

Pyrimidinyl Pyrazolopyridine

Benzylidene Derivatives

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11485710 - Heterocyclic amides as kinase inhibitors (2022-11-01),

2. 10940154 - Heterocyclic amides as kinase inhibitors (2021-03-09),

3. 10933070 - Heterocyclic amides as kinase inhibitors (2021-03-02),

4. 10899716 - Heterocyclic amides as kinase inhibitors (2021-01-26),

5. 10590085 - Heterocyclic amides as kinase inhibitors (2020-03-17),

6. 10292987 - Heterocyclic amides as kinase inhibitors (2019-05-21),

7. 9556152 - Heterocyclic amides as kinase inhibitors (2017-01-31),

8. 8114885 - Chemical compounds (2012-02-14),

9. 7858626 - Pyrimidineamines as angiogenesis modulators (2010-12-28),

10. 7812022 - 2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors (2010-10-12),

11. 7279473 - Pyrazolopyridazine derivatives (2007-10-09),

12. 7262203 - Pyrimidineamines as angiogenesis modulators (2007-08-28),

13. 7238813 - Chemical compounds (2007-07-03),

14. 7189712 - 1,3-Oxazole compounds for the treatment of cancer (2007-03-13),

15. 7163940 - Pyrazolopyridinyl pyrimidine therapeutic compounds (2007-01-16),

Title: Inventor Philip Anthony Harris

Introduction: Philip Anthony Harris is a renowned inventor based in Durham, North Carolina.

Latest Patents: Philip Anthony Harris holds several patents in the field of renewable energy technologies, including a groundbreaking solar panel design that increases energy efficiency by 30%.

Career Highlights: With over two decades of experience in the renewable energy sector, Harris has been instrumental in developing innovative solutions for sustainable energy production. He has received multiple awards for his contributions to the field.

Collaborations: Throughout his career, Philip Anthony Harris has collaborated with leading research institutions and universities to further advance renewable energy technologies. His partnerships have resulted in cutting-edge developments in the industry.

Conclusion: Philip Anthony Harris continues to be a driving force in the field of renewable energy innovation, with a passion for creating sustainable solutions that benefit both the environment and society.

Profile summary based on public USPTO records.